lncRNA | Expression | Target | miRNAs | Type of biomarker | Type of sample | References |
RNA HCP5 | Up | HDAC9 | miR-3619-5p | Anti-tumoral | HXO-RB44, Y79, SO-RB50, Weri-Rb1;Tissue human | [41] |
IncRNA CCAT1 | Up | c-Myc | miR-218-5p; | Proliferation, migration, invasion; EMT; apoptosis | SO-RB50; Y79; WERI-RB1 | [27] |
IncRNA DANCR | Up | MMP-9 | miR-34c; miR-613 | Proliferation, migration, invasion; EMT | Weri-Rb1, Y79, SO-RB50, HXO-RB44) and tumor tissues | [42] |
IncRNA NEAT1 | Up | CXCR4 | miR-204; miR-124 | Proliferation; Migration; | Weri-Rb1, Y79, SO-RB50) and tumor tissues | [23] |
lncRNA XIST | Up | STAT3; SOX4; ZEB1; ZEB2 | miR-124; miR-140-p; miR-191-5p; miR-101 | Proliferation; Migration; Invasion | Y79; Tissue human | [30] [31] |
IncRNA HOXA11-AS | Up | NEK3 | miR-506-3p | Metastasis; Development | HXO-RB44, Y79, SO-RB50, Weri-Rb1 | [43] |
lncRNA TUG1 | Up | H6PD | miR-516b-5p | Progession; Epithelial-Mesenchymal Transition | HXO-RB44, Y79, SO-RB50, Weri-Rb1; Tissue human | [37] [44] |
lncRNA PVT1 | Up | NOTCH | miR-488-3p; miR-124 | Progession | HXO-RB44, Y79, SO-RB50, Weri-Rb1;Tissue human | [35] |
lncRNA PROX1-AS1 | Up | SOX2 | miRNA-519d-3p | Drug Resistence; Proliferation, Migration; Invasion | HXO-RB44, Y79, SO-RB50, Weri-Rb1;Tissue human | [38] |
lncRNA MALAT1 | Up |
| miR-124/STX17, miR-20b-5p/STAT3, miR-655-3p/ATAD2 and miR-124/Slug axis | Proliferation, Migration; Invasion; EMT | HXO-RB44, Y79, SO-RB50, Weri-Rb1;Tissue human | [39] [45] |
lncRNA MKLN1 | Down |
|
| Tumorogenesis | Y79; WERI-RB1 | [46] |
lncRNA HOTAIR | Up | RRM2; PI3K; AKT | miR-613; miR-20b-5p | Proliferation; Epithelial-Mesenchymal Transition | Y79 | [28] [29] |
lncRNA KCNQ1OT1 | Up | SIRT1; JUNK | miR-217; miR-212-3; miR-504 | Proliferation; Migration | HXO-RB44, Y79, SO-RB50, Weri-Rb1; Tissue human | [40] |